Prediabetes lab results: the window where you can still change the trajectory
Anchor biomarkers: HbA1c, fasting glucose, fasting insulin
TL;DR
- •Prediabetes is a decision point, not a diagnosis. HbA1c 5.7 – 6.4 and fasting glucose 100 – 125 mean the body is signaling well before clinical diabetes — and reversal is still very achievable.
- •"Borderline" numbers are not noise. Roughly 70% of prediabetic adults progress to type 2 diabetes within 10 years without intervention. The other 30% reverse, plateau, or improve.
- •The numbers your doctor probably didn't check — fasting insulin and trig/HDL ratio — tell you how much metabolic runway you actually have.
What each marker tells you
| Marker | Reference range | What it means |
|---|---|---|
| HbA1c | 5.7 – 6.4% | Average glucose over 3 months sitting just above the optimal threshold. |
| Fasting glucose | 100 – 125 mg/dL | Snapshot of overnight-fasted glucose entering "impaired fasting glucose" territory. |
| Oral glucose tolerance test (2-hr) | 140 – 199 mg/dL | Post-challenge glucose response. Catches "impaired glucose tolerance" cases that fasting numbers miss. |
| Fasting insulin | typically > 10 µIU/mL by the time HbA1c is in prediabetic range | The engine. Tells you whether your pancreas is straining to keep up. |
| HOMA-IR | typically > 2.0 | Calculated insulin resistance index. > 2.5 indicates clear insulin resistance. |
| Triglycerides | often > 150 mg/dL | Rises with insulin resistance. |
| HDL | often < 50 (women) / < 40 (men) | Drops with insulin resistance. |
The "fine until you're not" trap: many patients are told "your A1C is just slightly elevated, no need to worry" and given no follow-up plan. Without intervention the trajectory is rarely flat.
Three real patterns Phi has seen
Example patterns · synthetic data drawn from Phi's scenario library. Not real patient records.
Pattern 1 — The "early prediabetic with full metabolic warning."
HbA1c 5.8. Fasting glucose 104. Fasting insulin 19. HOMA-IR 4.9. Triglycerides 178. HDL 42. The patient is told "watch your diet" with no further plan. The real read: this is *active metabolic dysfunction* — full insulin resistance with glucose just starting to spill into prediabetic range. Three to six months of targeted lifestyle work can typically pull all five markers back into healthy territory.
Example pattern · synthetic data
Pattern 2 — The "skinny prediabetic" / TOFI pattern (thin outside, fat inside).
HbA1c 5.9. Fasting glucose 102. Fasting insulin 14. HOMA-IR 3.5. Triglycerides 165. HDL 44. BMI 23 (normal weight). The patient is told "your weight is fine, your A1C is borderline — must be genetic." The real read: visceral adiposity drives metabolic disease independent of BMI. This patient has the same metabolic risk profile as someone 40 pounds heavier. Resistance training, dietary protein priority, and addressing sleep are usually the highest-leverage levers.
Example pattern · synthetic data
Pattern 3 — The "prediabetic on lifestyle reversal" pattern (6 months later).
HbA1c 5.5 (was 6.0). Fasting glucose 89 (was 110). Fasting insulin 7 (was 21). HOMA-IR 1.5 (was 5.7). Triglycerides 88 (was 195). HDL 52 (was 41). The patient walked 30 minutes a day after meals, ate protein at every meal, slept 7+ hours, and lost 14 pounds over 6 months. Every marker moved in the right direction. The pancreas is no longer straining. This is what an actual reversal trajectory looks like — and it's available to most prediabetic patients who get clear data and consistent inputs.
Example pattern · synthetic data
Questions to bring to your doctor
- Where has my HbA1c been over the last 2–3 annual checks — is the trajectory rising or stable?
- Have we checked fasting insulin? Without it we can't see how hard my pancreas is working.
- Can we add an oral glucose tolerance test? My fasting numbers may be missing post-meal spikes.
- What's my triglyceride-to-HDL ratio?
- Given I'm prediabetic, are there other complication-screening items we should run earlier (kidney function, retinal screening if I'm symptomatic)?
- What dietary patterns have you actually seen reverse prediabetes in your patient population?
- Would you be open to a continuous glucose monitor (CGM) trial to identify which foods spike my glucose most?
What Phi adds beyond a single number
Prediabetes is the easiest disease in modern medicine to *measure your way out of*. Every marker that moves the wrong way under insulin resistance also moves the right way under lifestyle change — usually within 3–6 months. Phi reads every panel you've ever uploaded, tracks the trajectory of HbA1c + fasting insulin + HOMA-IR + trig/HDL across time, and tells you whether your interventions are working *before* the next annual physical does.
Upload your most recent lab report. Phi will pull out every glucose- and insulin-relevant marker, compare them against optimal (not just reference) ranges, flag the pattern, and tell you what to ask at your next appointment.
Frequently asked questions
Is prediabetes actually a disease or just a category?
It's a transitional metabolic state with clear physiologic findings (insulin resistance, elevated fasting glucose, lipid changes). Whether it gets called "a disease" is more a billing convention than a clinical one. From a trajectory perspective, prediabetes is among the most modifiable conditions in medicine.
If my HbA1c is 5.7 (just over the line), is that the same as 6.4?
No. The risk gradient is meaningful across that range. 5.7–5.9 with normal fasting insulin and healthy lipids is a different situation than 6.3 with high insulin resistance markers. The number is one input — the full pattern is the diagnosis.
Can prediabetes reverse without medication?
Yes — lifestyle reversal is well-documented and is the first-line approach in clinical guidelines. The classic Diabetes Prevention Program study showed lifestyle change outperformed metformin for prevention of progression in most patient subgroups.
Should I take metformin "preventively" if I'm prediabetic?
Some guidelines support metformin in higher-risk prediabetics (especially with BMI > 35, history of gestational diabetes, or strong family history). It's a conversation worth having with your doctor — but it shouldn't substitute for the lifestyle work.
My doctor says "just lose weight." Is that enough?
Weight loss helps but isn't sufficient on its own. What moves insulin resistance most reliably: prioritizing protein, walking 10–20 minutes after meals, resistance training 2–3x/week, sleep ≥ 7 hours, and reducing late-evening eating. Weight often follows but isn't the cause-effect lever some doctors imply.
How often should I retest if I'm prediabetic?
Most guidelines suggest HbA1c every 6 months while monitoring. If you're actively intervening, retesting at 3 months can give you faster feedback on whether the interventions are working — though some markers (fasting insulin, lipid panel) move faster than HbA1c.
What's the difference between prediabetes and "borderline diabetes"?
"Borderline diabetes" isn't a clinical term — it usually means a primary-care doctor is hedging on whether to formally diagnose. In practice, prediabetic numbers (HbA1c 5.7 – 6.4) are the same numbers some doctors call "borderline." The action plan should be the same either way.
References
All citations verified against PubMed / publisher of record 2026-05-25.
- 1.American Diabetes Association Professional Practice Committee. (2024). Standards of Care in Diabetes—2024. Diabetes Care. 47(Suppl 1):S1-S321. — Current US standard for prediabetes diagnostic criteria (HbA1c 5.7–6.4, fasting glucose 100–125, OGTT 140–199).DOI →
- 2.Knowler WC, Barrett-Connor E, Fowler SE, et al. (Diabetes Prevention Program Research Group). (2002). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. New England Journal of Medicine. 346(6):393-403. — The DPP. Lifestyle intervention reduced incidence by 58%, metformin by 31%, vs placebo. Basis for the "reversal trajectory" framing.PubMed →DOI →
- 3.Diabetes Prevention Program Research Group. (2009). 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study (DPPOS). Lancet. 374(9702):1677-1686. — Long-term follow-up confirming durable lifestyle benefit.PubMed →DOI →
- 4.Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M. (2012). Prediabetes: a high-risk state for diabetes development. Lancet. 379(9833):2279-2290. — Synthesis on prediabetes physiology and progression rates (5–10% per year; ~70% over 10 years without intervention). Basis for the "70% progress in 10 years" framing.PubMed →DOI →
- 5.Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. (1985). Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 28(7):412-419. — Original HOMA-IR derivation; basis for HOMA-IR thresholds throughout this page.PubMed →DOI →
- 6.McLaughlin T, Abbasi F, Cheal K, Chu J, Lamendola C, Reaven G. (2003). Use of metabolic markers to identify overweight individuals who are insulin resistant. Annals of Internal Medicine. 139(10):802-809. — Basis for the triglyceride-to-HDL ratio cutoff (3.0 US units) as insulin resistance marker.PubMed →DOI →
"Fasting insulin optimal < 5 µIU/mL" and "HOMA-IR < 1.5 optimal" reflect functional/longevity-medicine practice positions rather than ADA guideline cutoffs. Every link above opens the PubMed abstract or publisher's DOI landing page in a new tab. All citations verified vs PubMed / publisher of record 2026-05-26.
By Steve Pinedo
Co-founder, Phi Longevity
Last updated: 2026-05-26
Steve Pinedo is the Co-founder of Phi Longevity, the AI application that turns a confusing stack of lab reports, wearable data, and clinical notes into a single, integrated picture of your health. He started Phi Longevity to make proactive health and wellness far easier to achieve. He realized how difficult it was for clients to manage their own care, records and coordination so he assembled a comprehensive M.D. led clinical team behind the platform, packaging the proactive-care experience that delivered measurable outcomes (lower triglycerides, reduced body fat, improved LDL, balanced hormones, relief from long-running autoimmune conditions) for any patient with a complicated lab to use now with an application. More about Phi →